Summary: Aggregation of α-synuclein and formation of inclusions are hallmarks of Parkinson’s disease (PD). Aggregate formation is affected by cellular environment, but it has been studied almost exclusively in cell-free systems. We quantitatively analyzed α-synuclein inclusion formation and clearance in a yeast cell model of PD expressing either wild-type (WT) α-synuclein or the disease-associated A53T mutant from the galactose (Gal)-inducible promoter. A computer-controlled microfluidics device regulated α-synuclein in cells by means of closed-loop feedback control. We demonstrated that inclusion formation is strictly concentration dependent and that the aggregation threshold of the A53T mutant is about half of the WT α-synuclein (56%). We...
Parkinson’s disease (PD) is a neurodegenerative disorder associated with the misfolding and aggregat...
Alpha-synuclein (α-SYN) aggregates represent a key feature of Parkinson's disease, but the exact rel...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by bradykinesia, ...
Highlights • In silico feedback control enables regulation of α-synuclein expression in yeast • α-...
Data, computational software, and supplemental movies generated in the study: "Quantitative Characte...
Protein misfolding and aggregation characterizes the development of a number of neurodegenerative di...
The presence of α-synuclein protein inclusions in the brain is a central pathological hallmark of Pa...
The misfolding and aggregation of the protein α-synuclein is the likely cause of Parkinson’s disease...
The intercellular prion-like propagation of protein aggregation is an important mechanism in the pro...
Alpha-Synuclein (α-Syn) is a protein mostly found in the presynaptic terminal of neurons in the brai...
Aggregation of ?-synuclein plays a crucial role in the pathogenesis of synucleinopathies, a group of...
Summary: Studying Parkinson’s disease (PD) is complex due to a lack of cellular models mimicking key...
Parkinson disease is the second most common neurodegenerative disease. The molecular hallmark is the...
Background: The hallmark of Parkinson disease is -synuclein aggregation, whose cytotoxic effects are...
Background. Improper folding and accumulation of a-synuclein aggregates are among the causes of Park...
Parkinson’s disease (PD) is a neurodegenerative disorder associated with the misfolding and aggregat...
Alpha-synuclein (α-SYN) aggregates represent a key feature of Parkinson's disease, but the exact rel...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by bradykinesia, ...
Highlights • In silico feedback control enables regulation of α-synuclein expression in yeast • α-...
Data, computational software, and supplemental movies generated in the study: "Quantitative Characte...
Protein misfolding and aggregation characterizes the development of a number of neurodegenerative di...
The presence of α-synuclein protein inclusions in the brain is a central pathological hallmark of Pa...
The misfolding and aggregation of the protein α-synuclein is the likely cause of Parkinson’s disease...
The intercellular prion-like propagation of protein aggregation is an important mechanism in the pro...
Alpha-Synuclein (α-Syn) is a protein mostly found in the presynaptic terminal of neurons in the brai...
Aggregation of ?-synuclein plays a crucial role in the pathogenesis of synucleinopathies, a group of...
Summary: Studying Parkinson’s disease (PD) is complex due to a lack of cellular models mimicking key...
Parkinson disease is the second most common neurodegenerative disease. The molecular hallmark is the...
Background: The hallmark of Parkinson disease is -synuclein aggregation, whose cytotoxic effects are...
Background. Improper folding and accumulation of a-synuclein aggregates are among the causes of Park...
Parkinson’s disease (PD) is a neurodegenerative disorder associated with the misfolding and aggregat...
Alpha-synuclein (α-SYN) aggregates represent a key feature of Parkinson's disease, but the exact rel...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by bradykinesia, ...